EULAR is excited to announce a change in its presidency, as Prof Annamaria Iagnocco, Italy, will be stepping down as President and handing over the ro..
In its final clinical trial, a new drug for treating the autoimmune disease rheumatoid arthritis has proved to be at least as effective as the current "gold standard" treatment. This opens up new treatment options for affected patients.